Targeted Strategies for Today's Evolving Markets

MissionIR Blog

MissionIRNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Adjourns Voting for Proposals Three and Four from Annual Meeting of Shareholders

India Globalization Capital, Inc. (NYSE American: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced that it has adjourned the voting for proposals three and four from its notice of annual meeting of shareholders, dated October 5, 2017. Proposal three seeks approval for the grant of 1.9 million shares of common stock, to be granted from time to time to the company’s current and new employees, advisors, directors and consultants by the board of directors. Proposal four seeks approval for the issuance of up to two million shares of the company’s common stock to Bricoleur Partners, L.P. Voting on these two proposals will now be adjourned to December 29, 2017, allowing IGC stockholders additional time to vote. Per the update, stockholders who have not yet voted can do so before December 29, 2017, at 11:59 pm EST by visiting www.ProxyVote.com, calling 800-454-8683 or returning a properly executed proxy card to InvestorCom.

To view the full press release, visit http://dtn.fm/PA46j

About IGC

IGC is engaged in the development of cannabis based combination therapies to treat Alzheimer’s, pain, nausea, eating disorders, several end points of Parkinson’s, and epilepsy in dogs and cats. IGC has assembled a portfolio of patent filings and four lead product candidates addressing these conditions. The company is based in Maryland, USA. For more information please visit www.igcinc.us

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in India Globalization Capital, Inc. IGC, MissionIRNewsBreaks | Leave a comment

Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF) in Production Mode as Utilities Plug into Grid-Scale Battery Installations

  • Demand for large grid-connected lithium batteries climbing
  • Demand from electric vehicle industry also rising
  • Company expanding exploration and production activities to meet demand

Utilities all around the world are plugging into lithium batteries, a trend that is establishing a new paradigm in the energy industry. Long employed at the micro level to power electrical and electronic devices, lithium batteries are now being employed at the macro level to power entire cities. Power utilities, in an effort to increase reliability of supply, are hooking up giant lithium battery installations to their grids. Already pressured by requirements from the electric vehicle (EV) industry, demand for lithium is set to increase. That development is spurring Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF) to intensify its exploration efforts, as it recently added 6,000 more acres to its Bristol Dry Lake Lithium Project. The company is aiming to become a significant low-cost, domestic producer of battery-grade lithium materials.

In February 2017, the largest grid-tied lithium-ion battery system in the U.S. was completed by the Southern California utility San Diego Gas & Electric (SDG&E). This massive energy storage facility was constructed after state officials mandated power companies to add lithium-ion battery storage to their grids, according to Ars Technica (http://dtn.fm/Jkem1). The directive was prompted by a massive methane leak at the Aliso Canyon natural gas storage facility operated by the Southern California Gas Company (SoCalGas). The SDG&E grid-tied lithium-ion storage facility has a 30MW battery system capable of storing 120MWH of energy, enough to serve 20,000 customers for four hours.

Despite its recent commissioning, the scale of the SDG&E facility has already been exceeded. In November 2017, the South Australian government announced the completion of the world’s largest lithium-ion battery just outside the city of Jamestown (http://dtn.fm/FcBj0). The battery behemoth can store 129 MWH of energy and deliver 100MW of power. It was built by Tesla (NASDAQ: TSLA) and is meant to reduce the incidence of recent power outages, one of which affected an area the size of France. Although often confused, power and energy and their units of measurement are distinctly different. Energy (megawatt-hours) can be compared to a reservoir of water that is part of a hydro-electric facility. The larger the size of the dam, the more potential energy the facility possesses. However, power (megawatts), the rate at which that potential energy is converted to usable form, is equally important.

As these developments continue, Standard Lithium is expanding its operations in California. The company recently announced (http://dtn.fm/Fl4gh) its entry into a memorandum of understanding with TETRA Technologies, Inc. (NYSE: TTI) aimed at securing access to additional operating and permitted land of approximately 12,100 acres in Bristol Dry Lake and up to 11,840 acres in the adjacent Cadiz Dry Lake of California’s Mojave Desert. The Bristol Dry Lake is a flat salt dry lake, or playa, that occupies approximately 155 sq. km in a 2,000 sq. km arid drainage basin. The actual project area covers over 25,000 acres of the playa. Standard Lithium recently signed a mineral lease agreement with National Chloride Corporation of America, which has, in the past, mined the near-surface brines to produce concentrated chloride products for various industrial applications. As a result, a lot of the required infrastructure is already in place.

The property, situated approximately 200 km from Las Vegas and 330 km east of the port of Los Angeles, has electric power and water and is crossed in the northwest by a major paved road (Route 66). There is also a Burlington Northern Santa Fe railroad adjacent to the site with a purpose-built siding and loading spur-line.

However, extensive as they are, its California assets are not all that Standard Lithium has to offer. The company is also exploring for lithium in the Smackover Formation, which extends through Texas, Arkansas and Louisiana, and has produced billions of barrels of brines over the last 80 years from an extensive and extremely well-characterized aquifer.

As global demand for lithium continues to climb, Standard Lithium is ramping up its exploration and product activities. The Canada-based junior exploration company continues to acquire lithium rich properties in the U.S. It plans to unlock value from overlooked U.S. lithium assets by applying new technologies and processes.

For more information, visit the company’s website at www.StandardLithium.com

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Standard Lithium Ltd. STLHF | Leave a comment

MissionIRNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Issues Update on Efforts to Roll Out Alzheimer’s Product Hyalolex

India Globalization Capital (NYSE: IGC) today provided investors and interested parties an update on its efforts to launch its principle product for relieving the anxiety, sleep disorders and brain afflictions associated with Alzheimer’s Disease via medical cannabis dispensaries throughout the United States in the next few months. The company stated that dispensaries in Washington, D.C. and Maryland have been identified as initial distribution sites to launch the product once final inventory is secured. Inventory is expected to be secured early next year. Expansion to additional U.S. states will occur next dependent on product procurement and associated compliance achievement. The Medical Marketing Group, Inc., a provider of outsourced product-detailing, education and outreach services, has been engaged to assist with national dispensary expansion ambitions.

To view the full press release, visit http://dtn.fm/Unn1N

About IGC

IGC is engaged in the development of cannabis based combination therapies to treat Alzheimer’s, pain, nausea, eating disorders, several end points of Parkinson’s, and epilepsy in dogs and cats.  IGC has assembled a portfolio of patent filings and four lead product candidates addressing these conditions. The company is based in Maryland, USA. For more information, please visit www.IGCinc.us.

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in India Globalization Capital, Inc. IGC, MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – Victory Square Technologies Inc. (CSE: VST) (OTC: VSQTF) (FRANKFURT: 6F6) (WKN: A2AKL8) Names Strategic Advisor for Growth of Blockchain Portfolio

Victory Square Technologies (CSE: VST) (OTC: VSQTF) (FRANKFURT: 6F6) (WKN: A2AKL8) today reported appointment of Guy Halford-Thompson to its Advisory Board. A co-founder of BTL Group (TSX-V: BTL) (OTC: BTLLF), Mr. Halford-Thompson is globally recognized as a pioneer and visionary in blockchain technology and his expertise will leverage growth and scaling of Victory Square’s current portfolio of blockchain companies. Mr. Halford-Thompson’s experience includes the investment and incubation of his company, the BTL Group, which was Canada’s first publicly traded blockchain company and has grown to a TSX Venture Exchange market cap of $250M. Of the appointment, Shafin Diamond Tejani, CEO of Victory Square, stated, “Guy has been a thought-leader in the blockchain space for years and has had tremendous success building one of Canada’s premier blockchain companies, the BTL Group. We are extremely excited and fortunate to have him join Victory Square due to his extraordinary vision and foresight on how blockchain will disrupt verticals that our portfolio companies operate in, such as Gaming, Health, Fintech, VR/AR/MR, and AI.”

To view the full press release, visit http://dtn.fm/9Oing

About Victory Square Technologies Inc.

Victory Square is a venture builder that creates, funds and empowers entrepreneurs predominantly focused on Blockchain Technology, Virtual Reality, Artificial Intelligence, Personalized Health, Gaming and Film. As a technology incubator, Victory Square invests in game-changing entrepreneurs who are provided access to education programs, global mentorship networks, distribution partners, creative workspaces, resources and other forms of operational support to help them scale internationally. For more information, visit the company’s website at www.victorysquare.com.

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in MissionIRNewsBreaks, Victory Square Technologies Inc. VSQTF | Leave a comment

MissionIRNewsBreaks – Pressure BioSciences, Inc. (PBIO) Acquires All Assets of BaroFold, Inc.

Pressure BioSciences (OTCQB: PBIO) today reported the acquisition of all assets of BaroFold, Inc. The assets acquired include all patents, equipment, and intellectual property relating to BaroFold’s PreEMT™ high-pressure protein refolding technology. A total of eight issued patents and several pending significantly enhances PBIO’s hold of intellectual property in high-pressure technologies. “In addition to the expected increase in revenue from instrument and consumable sales to customers developing biopharmaceutical manufacturing applications with the PreEMT technology, we expect the BaroFold acquisition to have positive effects on our services revenue as well. In this regard, we plan to continue the biologics contract research services program previously provided by Barofold. This entails extensive revenue-generating studies on the advantages of high-pressure processing in the manufacture of biopharmaceutical products using the patented PreEMT technology. We will also offer manufacturing-scale licenses to biopharmaceutical companies ready to take advantage of the PreEMT technology for more efficient production of their high-quality biological products. We believe such licenses have the potential to generate millions of dollars annually in royalty revenue,” Pressure Biosciences president and CEO Richard T. Schumacher stated in the news release.

To read the full press release, visit http://dtn.fm/3LsbX

About Pressure BioSciences, Inc.

Pressure BioSciences, Inc. (“PBI”) (OTCQB: PBIO) develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the estimated $6 billion life sciences sample preparation market. The company’s products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions. PBI’s primary focus is in the development of PCT-based products for biomarker and target discovery, drug development and design, bio-therapeutics characterization, soil & plant biology, forensics, and counter-bioterror applications. Major new focal market opportunities are emerging in the use of the company’s patented, scalable, high-efficiency Ultra Shear Technology (“UST”) to create stable nanoemulsions of otherwise immiscible fluids (such as oils and water), and to prepare higher quality, homogenized, extended shelf-life or room temperature stable, low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. For more information, visit the company’s website at www.PressureBiosciences.com.

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in MissionIRNewsBreaks, Pressure BioSciences Inc. PBIO | Leave a comment

MissionIRNewsBreaks – Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF) Provides Progress Update on California Lithium Project

Standard Lithium. (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF) today provided an update on the progress of its development work at the California Lithium Project, which is comprised of Mojave Desert, California area Bristol Dry Lake and Cadiz Dry Lake lithium brine properties. Progress, to date, includes installation of six new separate evaporation ponds on the Bristol Dry Lake Property designed to further assess the role of short-duration passive solar evaporation in processing the project’s lithium brines. Due to extremely high evaporation rates in the project area, previous work demonstrated the potential to concentrate brines from initial lithium concentrations of 146 mg/L to concentrations of 686 mg/L in approximately 7 weeks. (This average concentration was previously reported as 556 mg/L, but has been revised upwards based on final QA/QC data). Additional evaporation tests are continuing in order to assess evaporation rates according to seasonal variations and for the production of large volumes of pre-concentrated brine for shipment to Standard Lithium’s testing facilities across North America for use in ongoing selective lithium extraction processing. In addition, over the next several weeks, a bulk raw-brine sample from the Cadiz Dry Lake Project will be transported to the evaporation ponds to assess pre-concentration of lithium brine from this project.

To view the full press release, visit http://dtn.fm/Tgc3q

About Standard Lithium Ltd.

Standard’s value creation strategy encompasses acquiring a diverse and highly prospective portfolio of large-scale domestic brine resources, led by an innovative and results-oriented management team with a strong focus on technical skills. The company is currently focused on the immediate exploration and development of the Bristol Dry Lake Lithium Project located in the Mojave region of San Bernardino County, California; the location has significant infrastructure in-place, with easy road and rail access, abundant electricity and water sources, and is already permitted for extensive brine extraction and processing activities. The company is also commencing resource evaluation on 33,000 acres of brine leases located in the Smackover Formation. For more information, visit http://nnw.fm/standardlithium.

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in MissionIRNewsBreaks, Standard Lithium Ltd. STLHF | Leave a comment

MissionIRNewsBreaks – Pressure BioSciences, Inc. (PBIO) Technology Helps Maintain Integrity of Lab Science

Amid the requirements for maintaining uncompromised sampling in laboratory research, Pressure BioSciences, Inc. (PBIO) is delivering a proprietary technology that can control the preparation of scientific samples in a critical and unprecedented way. This allows researchers to begin their experimentation with the assurance of using biological products that are unmatched in their quality and most likely to produce sound science as a result. An article discussing this reads: “PBIO’s product line is based on a patented, enabling technology platform called pressure cycling technology (PCT), which employs alternating cycles of hydrostatic pressure — ranging between ambient (14.5 psi) and ultra-high levels (up to 100,000 psi) — to safely and reproducibly control critical biological processes. For example, one of these processes is lysis, or the breakage of cells. Traditionally, when cells are ruptured for study, they must be broken open using chemicals, blades, metal beads, sound waves or other inadequate methods that can damage and alter the invaluable biomolecules inside the cells. … With PBIO’s pioneering PCT technology, however, the lysis process is controlled like never before.”

To read the full article, visit http://dtn.fm/hH2Qx

About Pressure BioSciences, Inc.

Pressure BioSciences, Inc. (“PBI”) (OTCQB: PBIO) develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the estimated $6 billion life sciences sample preparation market. The company’s products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions. PBI’s primary focus is in the development of PCT-based products for biomarker and target discovery, drug development and design, bio-therapeutics characterization, soil & plant biology, forensics, and counter-bioterror applications. Major new focal market opportunities are emerging in the use of the company’s patented, scalable, high-efficiency Ultra Shear Technology (“UST”) to create stable nanoemulsions of otherwise immiscible fluids (such as oils and water), and to prepare higher quality, homogenized, extended shelf-life or room temperature stable, low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. For more information, visit the company’s website at www.PressureBiosciences.com.

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in MissionIRNewsBreaks, Pressure BioSciences Inc. PBIO | Leave a comment

WPCS International, Inc., (NASDAQ: WPCS) Subsidiary Signs Definitive Agreement to Merge with DropCar, Inc., Anticipates Name Change and New Ticker Symbol

  • Consummation of transaction is anticipated late in calendar 2017, with the merger calling for WPCS to be renamed DropCar after the closing; stock would continue to trade on NASDAQ under a ticker symbol proposed as DCAR
  • Spencer Richardson, DropCar co-founder and CEO, would be CEO of the new entity; Sebastian Giordano, WPCS CEO, would serve on newly merged company’s board
  • Goal for WPCS is to offer greater shareholder value for its stockholders; when merger is completed, WPCS shareholders would hold 16% of the outstanding common stock in the merged entity while DropCar’s shareholders and advisors would hold the remaining 84%

WPCS International, Inc. (NASDAQ: WPCS), through a wholly-owned subsidiary, has signed a definitive agreement to merge with privately-owned DropCar, Inc. The surviving entity will be named DropCar and the company’s common stock is proposed to trade on the NASDAQ Capital Market under ticker symbol DCAR, according to a December 7, 2017 WPCS SEC S-4 amendment filing.

WPCS will acquire DropCar in an all-stock transaction, the companies announced (http://dtn.fm/hQu6O). The transaction is expected to be consummated late in the fourth quarter of CY 2017. Sebastian Giordano, CEO of WPCS, would serve on the board of the new entity. Spencer Richardson, co-founder and CEO of DropCar, will be CEO of the merged entity.

WPCS is a California-based, low-voltage solutions provider. It installs and services integrated structured cabling, audio-visual and security services for public services, healthcare, energy, and corporate enterprise markets in the U.S.  DropCar offers a cloud-based logistics and vehicle support platform designed to reduce the costs and hassles of owning a car in an urban center.

“This is a new and exciting chapter for WPCS,” Giordano said, explaining that the transaction would enable DropCar to “leverage its technology” and grow in the automotive support and logistics market.

Richardson added in a conference call that DropCar plans to expand into major cities worldwide in the future and said that the company already has more than 1,000 subscriber customers (http://dtn.fm/ZMyg4). He called the company “well positioned” to grow as a destructor within the platform of automotive logistics.

When the transaction is completed, it is anticipated that WPCS common stock shareholders would hold 16% of the new entity’s common, while DropCar’s shareholders and advisors would hold the remaining 84%. However, as a December 4, 2017 SEC 8K filing shows, the actual percentages will be tweaked and modified by amendments to the merger agreement.  Conditions to the closing call for DropCar to raise at least $4 million prior to consummation.

WPCS International offers full service and low-voltage end-to-end solutions. It can transform organizations with new ways to connect their services, communications, and resourcing.

DropCar, founded and launched in New York City in 2015 offers a cloud-based platform and mobile app that coordinates the activities of trained valets in urban centers. They move cars from secured garages to/from the people who own them. It targets, as its customers, both consumers and businesses, including dealerships and shared mobility companies. They use DropCar’s streamlined logistics for parking, taking the cost and hassle out of owning a car in a congested city.

DropCar recently signed a definitive agreement with Toyota of Manhattan for that dealership to utilize its Enterprise Vehicle Assistance & Logistics (“VAL”) platform, which offers tech logistics in the handling of service and delivery of vehicles.

For more information, visit www.WPCsir.com or www.DropCar.com

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Small Cap News | Leave a comment

MissionIRNewsBreaks – VistaGen Therapeutics, Inc. (NASDAQ: VTGN) Advances IP for Lead Product Candidate with New Methods of Production Patent

Clinical-stage biopharmaceutical company VistaGen Therapeutics (NASDAQ: VTGN) recently announced that it has been issued U.S. Patent No. 9,834,801 by the U.S. Patent and Trademark Office (“USPTO”), strengthening its intellectual property (“IP”) stance. The newly-issued patent covers certain methods of production for AV-101, VistaGen’s lead central nervous system (“CNS”) product candidate. “This issued U.S. patent, in conjunction with the potential issuance of additional AV-101 patent applications currently under review worldwide, provides VistaGen with added long-term intellectual property protection for AV-101 and enhances its commercial potential,” VistaGen CEO Shawn Singh stated in the news release.

To view the full press release, visit http://dtn.fm/fo08S

About VistaGen

VistaGen Therapeutics, Inc. (NASDAQ: VTGN) is a clinical-stage biopharmaceutical company focused on developing new generation medicines for depression and other CNS disorders. VistaGen’s lead CNS product candidate, AV-101, is in Phase 2 development, initially as a new generation oral antidepressant drug candidate for major depressive disorder (MDD). AV-101′s mechanism of action is fundamentally different from all FDA-approved antidepressants and atypical antipsychotics used adjunctively to treat MDD, with potential to drive a paradigm shift towards a new generation of safer and faster-acting antidepressants. AV-101 is currently being evaluated by the National Institute of Mental Health (NIMH) in a small Phase 2 monotherapy study in MDD being fully funded by the NIMH and conducted by Dr. Carlos Zarate Jr., Chief, Section on the Neurobiology and Treatment of Mood Disorders and Chief of Experimental Therapeutics and Pathophysiology Branch at the NIMH. VistaGen is preparing to launch a 180-patient Phase 2 study of AV-101 as an adjunctive treatment for MDD patients with an inadequate response to standard, FDA-approved antidepressants, with Dr. Maurizio Fava of Harvard University as Principal Investigator. AV-101 may also have the potential to treat multiple CNS disorders and neurodegenerative diseases in addition to MDD, including neuropathic pain, epilepsy, Huntington’s disease, Parkinson’s disease levodopa-induced dyskinesia and other disorders where modulation of the NMDA receptors, activation of the AMPA neurotransmitter pathways and/or key active metabolites of AV-101 may achieve therapeutic benefit. For more information, visit the company’s website at www.VistaGen.com.

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF) Well Positioned in Growing Market for Lithium as Momentum Gains

Lithium mining companies such as Standard Lithium (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF) are racing to meet the surging demand for lithium while a scarce market supply forecasts an anticipated shortage by major producers. An article discussing this reads: “To exceed objectives and market expectations, Standard Lithium has established a world class Scientific Advisory Council of lithium extraction scientists and process engineers that is in charge of the lithium extraction process testing work (http://dtn.fm/un4Bn). As Standard Lithium CEO Robert Mintak stated, “Standard Lithium has a very clear focus…we have the ideal team with a blend of experience, knowledge, technical agility and pragmatic problem-solving abilities, to develop optimal process solutions for Standard Lithium’s world-class assets”. Standard Lithium is determined to produce low cost domestic lithium and capitalize on the immense global shortages.”

To view the full article, visit http://dtn.fm/PfAR7

About Standard Lithium Ltd.

Standard’s value creation strategy encompasses acquiring a diverse and highly prospective portfolio of large-scale domestic brine resources, led by an innovative and results-oriented management team with a strong focus on technical skills. The company is currently focused on the immediate exploration and development of the Bristol Dry Lake Lithium Project located in the Mojave region of San Bernardino County, California; the location has significant infrastructure in-place, with easy road and rail access, abundant electricity and water sources, and is already permitted for extensive brine extraction and processing activities. The company is also commencing resource evaluation on 33,000 acres of brine leases located in the Smackover Formation. For more information, visit http://nnw.fm/standardlithium.

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in MissionIRNewsBreaks, Standard Lithium Ltd. STLHF | Leave a comment